SCHEMBL5480068

SCHEMBL5480068

O=C(O)Cc1c[nH]c2c(OCc3ccccc3)cccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.67
PLA2G2A P14555 1/20 0.67
TRPM8 Q7Z2W7 1/20 0.67
PTGER1 P34995 1/20 0.52
PTGER4 P35408 1/20 0.52
PTGER3 P43115 1/20 0.52
PTGER2 P43116 1/20 0.52
ADRB3 P13945 4/20 0.49
CFD P00746 3/20 0.48
F11 P03951 3/20 0.48
TPSB2 P20231 3/20 0.48
PLG P00747 1/20 0.48
PLAU P00749 1/20 0.48
KLKB1 P03952 1/20 0.48
F7 P08709 1/20 0.48
MGLL Q99685 1/20 0.46
SRD5A2 P31213 1/20 0.45
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5479712 0.83 TRPM8 (0.76) LTA4HPLA2G2ATRPM8ADRB3MGLL
SCHEMBL837542 0.83 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3MGLL
SCHEMBL837541 0.83 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3MGLL
SCHEMBL16714058 0.82 LTA4H (0.60) LTA4HPLA2G2ATRPM8PTGER1MGLL
SCHEMBL27612134 0.82 LTA4H (0.71) LTA4HPLA2G2ATRPM8ADRB3MGLL
Oxalic Acid SCHEMBL7571181 0.81 LTA4H (0.62) LTA4HPLA2G2ATRPM8PTGER1PTGER4
SCHEMBL30708156 0.81 MTNR1A (0.62) ADRB3ADRB2MTNR1AMTNR1BADRB1
SCHEMBL21808835 0.81 MTNR1A (0.62) ADRB3ADRB2MTNR1AMTNR1BADRB1
SCHEMBL30579433 0.80 LTA4H (1.00) LTA4HPLA2G2ATRPM8ADRB3
SCHEMBL5167328 0.80 LTA4H (1.00) LTA4HPLA2G2ATRPM8ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217724-B2 Indole, indazole, and benzazole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-15 US disclosed
US-20060063762-A1 Indole indazole and benzazole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2006-03-23 US disclosed
EP-1514869-A1 INDOLE, INDAZOLE, AND BENZAZOLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063762-A1 Indole indazole and benzazole derivative ADRB3, ADRA2C, ADRB2 LTA4H 3017/4885PLA2G2A 3711/4885TRPM8 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.